Donor leukocyte infusions for the treatment of leukemia relapse after allogeneic hematopoietic cell transplantation with myeloablative conditioning

Turkish Journal of Haematology

Volumn 17, Issue 4, 2000, Pages 171-181

  Gurman G ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Allogeneic hematopoietic cell transplantation; Donor leukocyte infusion; Leukemia relapse

Indexed keywords

ACICLOVIR; ANTHRACYCLINE DERIVATIVE; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; HYDROXYUREA; IDARUBICIN; MELPHALAN; MITOXANTRONE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER GROWTH; CHIMERA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOPENIA; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; INFECTION; LEUKEMIA; LEUKEMIA REMISSION; LYMPHOCYTE TRANSFUSION; MALE; MONONUCLEAR CELL; RELAPSE; TREATMENT OUTCOME;

EID: 0034523409     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Leukemia relapse after allogeneic bone marrow transplantation: A review
2. Relapse of acute leukemia after bone marrow transplantation: Natural history and results of subsequent therapy
3. Second transplants for patients with chronic myeloid leukemia in relapse after original transplant with T-depleted donor marrow: Feasibility of using busulphan alone for reconditioning
4. Second bone marrow transplantation for leukemia in untreated relapse
5. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: Single center experience of 32 adult patients
6. Filgrastim for the treatment of leukemia relapse after bone marrow transplantation
7. G-CSF stimulation of donor myeolopoiesis prolongs survival of relapsed bcr-abl positive acute lymphoblastic leukemia after allogeneic marrow transplantation
8. Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia
9. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation
10. Interferon-alfa overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells
11. Il2/LAK therapy for refractory acute monoblastic leukemia relapsing after unrelated allogeneic bone marrow transplantation
12. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
13. Graft-versus-leukemia: Understanding and using the alloimmune response to treat haematological malignancies
14. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: Recovery complicated by initial pancytopenia and late dermatomyositis
15. Graft failure after donor leukocyte infusion in relapse chronic myeloid leukaemia: Successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion
16. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
17. Donor leukocyte infusion for relapsed ANLL after allogeneic BMT and the use of interferon alpha to induce graft-versus-leukemia effect
18. Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions
19. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia
20. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients
21. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation
22. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
23. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation
24. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
25. Induction of remission after donor leukocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: Evidence for a 'graft vs. myelofibrosis' effect
26. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
27. Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant - Equal efficacy of lymphocytes from sibling and matched unrelated donors
28. Kinetics of the graft versus leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation
29. Characterization of lineage-specific chimaerism in patients with acute leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse
30. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: Is T cell dose important in determining biological response?
31. Comparison of single dose and escalating dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
32. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: Impact of infused and residual donor T cells
33. Phenotypic changes in neutrophil granulocytes from healthy donors after G-CSF administration
34. Granulocyte colony-stimulating-factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease
35. Repeated peripheral stem cell mobilization in healthy donors: Time dependent changes in mobilization efficiency
36. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation
37. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
38. Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation
39. Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation
40. Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: The current leukaemia-free survival curve